Merck to seek authorization for oral Covid drug
Pharmaceutical company Merck said Friday it will seek authorization in the US for an oral drug for Covid-19, after the pill showed “compelling results” in a clinical trial.
Pharmaceutical company Merck said Friday it will seek authorization in the US for an oral drug for Covid-19, after the pill showed “compelling results” in a clinical trial.